Spotlight: Sikich — A Formula for Life Science Success

Sikich LLP is a 1000 member business advisory firm that offers technology and accounting services to a broad array of companies. In operation for more than 35 years, about 10 years ago the company started offering its services to life sciences companies, tailored to fit their specific needs. Big4Bio editor Marie Daghlian recently met virtually […]

Read More

Spotlight: Explora BioLabs — Powering Your Science

Explora BioLabs provides preclinical, AAALAC-accredited vivarium space and related services to clients of all sizes and in all stages of development. With 150,000 square feet of space across 11 locations in biotech-dense communities, the company prides itself on providing clients the ability to initiate preclinical in vivo programs in as little as two weeks, with […]

Read More

Spotlight: Cerevance Raises $45 Million to Advance Therapeutics Against Novel CNS Targets

by Marie Daghlian Cerevance has raised $45 million in a series B financing to continue deploying its platform to identify novel therapeutic targets for central nervous system diseases, and advance a pipeline of therapies for Parkinson’s disease, Alzheimer’s disease, and neuroinflammation. New investors GV, Bill Gates, and Foresite Capital joined previous investors Takeda Ventures, the […]

Read More

Big4Bio:SFBay COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. Local: SF.gov: […]

Read More

GigaGen Focuses Its Technology to Address COVID-19 Pandemic

by Marie Daghlian GigaGen announced that it is developing a recombinant polyclonal antibody therapy for the treatment of COVID-19, the pandemic coronavirus that has been sweeping the world and for which humans have no innate immunity. Based in South San Francisco, GigaGen spent the first seven years of its existence developing its single cell technology […]

Read More

Big4Bio:Philadelphia COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. Local: City […]

Read More

Big4Bio:Boston COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. Local: City […]

Read More

Big4Bio:San Diego COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. Local: City […]

Read More

SPOTLIGHT: Big4Bio:Boston 2019 Year-in-Review

Welcome to the first-ever Big4Bio Year-in-Review for the Boston region! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in Boston’s research, pharma, and biotech industries as you look ahead to a fruitful 2020. Compared to 2018, life sciences venture investment fell in Boston and across the United […]

Read More

SPOTLIGHT: Big4Bio:SFBay 2019 Year-in-Review

Welcome to the first-ever Big4Bio Year-in-Review for the San Francisco Bay Area! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in San Francisco Bay’s research, pharma, and biotech industries as you look ahead to a fruitful 2020. Here’s what you’ll find inside the Year-in-Review 2019 report: Data […]

Read More

SPOTLIGHT: Big4Bio:San Diego 2019 Year-in-Review

Welcome to the first-ever Big4Bio Year-in-Review for the San Diego region! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in San Diego’s research, pharma, and biotech industries as you look towards a productive 2020. The 2019 Year-in-Review report includes: Facts/data about the San Diego life sciences market […]

Read More

SPOTLIGHT: Big4Bio:Philadelphia 2019 Year-in-Review

Welcome to the first-ever Big4Bio Year-in-Review for the Philadelphia area! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in Philadelphia’s research, pharma, and biotech sectors as you look to a productive 2020. The Greater Philadelphia region has finally come into its own in the life science world! […]

Read More

Big4Bio Interview with Halloran Consulting Group’s Laurie Halloran and Katie McCarthy

Boston-based Halloran Consulting Group offers senior-level expertise to life science companies as they navigate the regulatory, clinical, and operational challenges at each stage of their development. At the beginning of October, Halloran announced several promotions in its organization, and the expansion of operations in San Diego, setting up a West Coast office there to better […]

Read More

Spotlight: Catching Up With CO.DON AG CEO, Ralf Jakobs

LaVoieHealthScience Client Spotlight: CO.DON CEO, Ralf Jakobs — Advancing Autologous Human Cell Transplants   Can you provide a brief overview of CO.DON and its focus? CO.DON is focused on the development, production and marketing of cell-based products for joint-preserving, regenerative treatment of articular cartilage defects. That’s all we do and where we have built our […]

Read More